Dubovsky Filip 4
4 · NOVAVAX INC · Filed Nov 7, 2023
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Dubovsky Filip
President, R&D
Transactions
- Exercise/Conversion
Common Stock
2023-11-05$7.06/sh+1,400$9,884→ 52,994 total - Exercise/Conversion
Restricted Stock Units
2023-11-05−1,400→ 0 total→ Common Stock (1,400 underlying) - Tax Payment
Common Stock
2023-11-05$7.06/sh−677$4,780→ 52,317 total
Footnotes (3)
- [F1]The shares were received by the reporting person in connection with vesting of restricted stock units ("RSUs").
- [F2]Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
- [F3]The RSUs subject to this grant under the Plan vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the November 5, 2020 grant date, in each case subject to continued employment with the Company through such vesting date.